(Q34730708)

4 August 2017

1 reference

title

Single-agent immunosuppression after liver transplantation: what is possible? (English)

1 reference

4 August 2017

1 reference

liver transplantation

1 reference

inferred from title

author

Andrew Kenneth Burroughs

series ordinal

2

object named as

Andrew K Burroughs

1 reference

4 August 2017

Maria L Raimondo

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

number of pages

11

1 reference

inferred from page(s)

published in

Drugs

1 reference

4 August 2017

volume

62

1 reference

4 August 2017

issue

11

1 reference

4 August 2017

page(s)

1587-1597

1 reference

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events

4 August 2017

cites work

1 reference

12 December 2020

Ten years of liver transplantation: an evolving understanding of late graft loss

1 reference

12 December 2020

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

1 reference

12 December 2020

Sirolimus (rapamycin)-based rescue treatment following chronic rejection after liver transplantation

1 reference

12 December 2020

Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins

1 reference

12 December 2020

A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation

1 reference

12 December 2020

Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.

1 reference

12 December 2020

Recurrent hepatitis C after liver transplantation

1 reference

12 December 2020

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.

1 reference

12 December 2020

Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

1 reference

12 December 2020

Weaning of immunosuppression in liver transplant recipients

1 reference

12 December 2020

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

1 reference

12 December 2020

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

1 reference

12 December 2020

Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis

1 reference

12 December 2020

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil

1 reference

12 December 2020

Sirolimus: a potent new immunosuppressant for liver transplantation

1 reference

12 December 2020

A randomized prospective trial of steroid withdrawal after liver transplantation.

1 reference

12 December 2020

The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis

1 reference

12 December 2020

Steroid side effects and their impact on transplantation outcome.

1 reference

12 December 2020

Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system

1 reference

12 December 2020

Weaning of immunosuppression in living donor liver transplant recipients

1 reference

12 December 2020

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

12 December 2020

Corticosteroid withdrawal after liver transplantation

1 reference

12 December 2020

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

12 December 2020

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem

1 reference

12 December 2020

CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION

1 reference

12 December 2020

Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated

1 reference

12 December 2020

Acute cellular rejection after liver transplantation: variability, morbidity, and mortality

1 reference

12 December 2020

Defining the outcome of immunosuppression withdrawal after liver transplantation

1 reference

12 December 2020

The immunoreactive propensity of autoimmune hepatitis: is It corticosteroid-dependent after liver transplantation?

1 reference

12 December 2020

Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim

1 reference

12 December 2020

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation

1 reference

12 December 2020

The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients

1 reference

12 December 2020

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

12 December 2020

Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function

1 reference

12 December 2020

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

1 reference

12 December 2020

Steroid withdrawal from long-term immunosuppression in liver allograft recipients

1 reference

12 December 2020

Daclizumab induction therapy in combination with tacrolimus

1 reference

12 December 2020

Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation

1 reference

12 December 2020

Immunosuppressive strategies in transplantation

1 reference

12 December 2020

Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).

1 reference

12 December 2020

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

1 reference

12 December 2020

A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin

1 reference

12 December 2020

Advances in transplantation tolerance

1 reference

12 December 2020

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

12 December 2020

Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients

1 reference

12 December 2020

Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation.

1 reference

12 December 2020

Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial

1 reference

12 December 2020

Daclizumab induction in liver transplant recipients

1 reference

12 December 2020

10.2165/00003495-200262110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1004015649

0 references

1 reference